• Hematology / Oncology @Point of Care Podcasts

  • By: @Point of Care
  • Podcast
Hematology / Oncology @Point of Care Podcasts By cover art

Hematology / Oncology @Point of Care Podcasts

By: @Point of Care
Listen for free

  • Summary

  • Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.
    Copyright 2020 At Point of Care, LLC. All rights reserved.
    Show more Show less
Episodes
  • S19:E3 – Morning Commute Podcast: What Clinicians Should Know about Treatment-Related Adverse Events from HER3-Directed ADCs in Breast and Lung Cancer

    S19:E3 – Morning Commute Podcast: What Clinicians Should Know about Treatment-Related Adverse Events from HER3-Directed ADCs in Breast and Lung Cancer
    Dec 29 2023

    Our faculty continue their discussion about clinical trials of HER3-directed therapies with a look at treatment-related adverse events and how to manage them.

    Visit www.morningcommutepodcast.com/HER3Agnostic3 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
    Show more Show less
    26 mins
  • S19:E2 – Morning Commute Podcast: A Review of Trial Data on HER3 in Non-Small Cell Lung Cancer and Breast Cancer

    S19:E2 – Morning Commute Podcast: A Review of Trial Data on HER3 in Non-Small Cell Lung Cancer and Breast Cancer
    Dec 29 2023

    In this episode our faculty take a look at the clinical trial data on HER3-directed therapies for breast and lung cancer.

    Visit www.morningcommutepodcast.com/HER3Agnostic2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
    Show more Show less
    31 mins
  • S19:E1 – Morning Commute Podcast: Should HER3 Be Considered a Tumor-Agnostic Target in Breast and Lung Cancer?

    S19:E1 – Morning Commute Podcast: Should HER3 Be Considered a Tumor-Agnostic Target in Breast and Lung Cancer?
    Dec 29 2023

    In this episode, our faculty discuss the widespread expression of human epidermal growth factor receptor 3 (HER3) across tumor types and why clinicians should have HER3 on their radar.

    Visit www.morningcommutepodcast.com/HER3Agnostic1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
    Show more Show less
    26 mins
Physical Illness & Disease Hygiene & Healthy Living
Show more Show less

What listeners say about Hematology / Oncology @Point of Care Podcasts

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available